Keurig Dr Pepper price target lowered to $34 from $37 at Barclays

Barclays analyst Lauren Lieberman lowered the firm’s price target on Keurig Dr Pepper to $34 from $37 and keeps an Overweight rating on the shares. The company guided to mid-single-digit organic sales and high-single-digit adjusted earnings growth in 2024, the analyst tells investors in a research note. The firm finds it challenging to build to that bottom line in its model given the meaningful uptick in interest expense slated for this year.